GLP-1 and health: Beyond weight loss in the Ozempic era

This week, the White House announced a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1 weight loss drugs, Wegovy and Zepbound. The move could significantly expand access to these treatments for people with diabetes and obesity.

Kennedy Walks a Tightrope on Trump Deal for Obesity Drugs – The New York Times

Kennedy Walks a Tightrope on Trump Deal for Obesity Drugs  The New York Times Opinion | How to Beat the High Cost of Weight-Loss Drugs  The Wall Street Journal Colorado doctors explain benefit after Trump announces plan to lower GLP-1 drug prices  CBS News What Trump’s GLP-1 weight-loss drug deal means for Long Island consumers  Newsday White House GLP-1 […]

The trend of unproven peptides is spreading through influencers and RFK Jr. allies

Andrea Steinbrenner receives an IV infusion at Pure Alchemy Wellness, Tuesday, Nov. 11, 2025, in Chula Vista, Calif. (AP Photo/Javier Arciga) 2025-11-14T05:03:15Z WASHINGTON (AP) — More Americans are injecting themselves with unapproved chemicals that are pitched as ways to build muscle, rejuvenate skin and extend life, the latest example of the nation’s fascination with alternative […]

GLP-1 weight-loss medications linked to improved cancer survival in certain patients

Colon cancer patients could live longer if they take GLP-1 drugs like Ozempic and Wegovy, a new study suggests. Researchers at UC San Diego studied more than 6,800 patients who were taking one of these popular similar diabetes and weight-loss medications. They found that the patients were much less likely to die within five years […]